Expert Interview
Discussing the potential of Tulisokibart (MK-7240) and SPY001, an investigational anti-TL1A monoclonal antibody being developed for the management of IBD.
Ticker(s): MRK, SYREInstitution: ProHEALTH Care Associates
- Board-certified in Internal Medicine and specializes in gastroenterology with 16+ years of experience
- treats all gastrointestinal and liver disorder with a clinical focus on Inflammatory Bowel Disease
- has performed dozens of FMT and treats about 10 patients per year for CDI/rCDI.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
